SUPPLEMENT INDIVIDUAL ARTICLE: Bridging the Gap: Optimizing Skin Care in Acne Treatment

December 2022 | Volume 21 | Issue 12 | SF3509933 | Copyright © December 2022


Published online November 30, 2022

Aaron S. Farberg MD FAADa,b, Divya Sharma MDc

aBare Dermatology, Dallas, TX
bSection of Dermatology, Baylor Scott & White Health System, Dallas, TX
cDepartment of Medicine, OhioHealth-Riverside Methodist Hospital, Columbus, OH

DISCLOSURES
Dr. Farberg is an Advisor for Galderma, Johnson & Johnson Consumer, Novartis, Orthodermatologics, and Sun Pharmaceuticals. Dr. Sharma has no conflicts of interest to declare.

REFERENCES
1. Jordan L, Baldwin HE. Stratum corneum abnormalities and disease-affected skin: strategies for successful outcomes in inflammatory acne. J Drugs Dermatol. 2016;15(10):1170-1173. PMID: 27741332.
2. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.e33. doi: 10.1016/j. jaad.2015.12.037. Epub 2016. Erratum in: J Am Acad Dermatol. 2020;82(6):1576. PMID: 26897386.
3. Del Rosso JQ. The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection. J Clin Aesthet Dermatol. 2013;6(12):19-27. PMID: 24765221; PMCID: PMC3997205.